SANUWAVE Health Inc (SNWV)
0.0209
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
SANUWAVE Health Enterprise Value: 49.93M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 49.93M |
| May 15, 2024 | 48.90M |
| May 14, 2024 | 48.78M |
| May 13, 2024 | 49.75M |
| May 10, 2024 | 52.22M |
| May 09, 2024 | 51.19M |
| May 08, 2024 | 51.19M |
| May 07, 2024 | 51.19M |
| May 06, 2024 | 49.93M |
| May 03, 2024 | 49.36M |
| May 02, 2024 | 52.21M |
| May 01, 2024 | 48.79M |
| April 30, 2024 | 46.51M |
| April 29, 2024 | 48.22M |
| April 26, 2024 | 49.36M |
| April 25, 2024 | 47.33M |
| April 24, 2024 | 52.21M |
| April 23, 2024 | 51.07M |
| April 22, 2024 | 50.50M |
| April 19, 2024 | 53.12M |
| April 18, 2024 | 53.24M |
| April 17, 2024 | 53.41M |
| April 16, 2024 | 49.93M |
| April 15, 2024 | 48.79M |
| April 12, 2024 | 48.22M |
| Date | Value |
|---|---|
| April 11, 2024 | 49.93M |
| April 10, 2024 | 47.76M |
| April 09, 2024 | 48.79M |
| April 08, 2024 | 47.93M |
| April 05, 2024 | 47.03M |
| April 04, 2024 | 48.33M |
| April 03, 2024 | 47.14M |
| April 02, 2024 | 47.31M |
| April 01, 2024 | 48.68M |
| March 31, 2024 | 50.56M |
| March 28, 2024 | 52.74M |
| March 27, 2024 | 52.76M |
| March 26, 2024 | 51.55M |
| March 25, 2024 | 52.12M |
| March 22, 2024 | 50.69M |
| March 21, 2024 | 50.98M |
| March 20, 2024 | 50.36M |
| March 19, 2024 | 50.75M |
| March 18, 2024 | 50.98M |
| March 15, 2024 | 50.98M |
| March 14, 2024 | 53.14M |
| March 13, 2024 | 52.69M |
| March 12, 2024 | 52.23M |
| March 11, 2024 | 53.26M |
| March 08, 2024 | 53.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
25.47M
Minimum
May 06 2022
116.76M
Maximum
Feb 28 2022
69.34M
Average
62.16M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 7.080M |
| Perspective Therapeutics Inc | 890.47M |
| Protalix BioTherapeutics Inc | 57.71M |
| Electromed Inc | 135.95M |
| Armata Pharmaceuticals Inc | 189.99M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.528M |
| Revenue (Quarterly) | 5.786M |
| Total Expenses (Quarterly) | 6.836M |
| EPS Diluted (Quarterly) | -0.0039 |
| Gross Profit Margin (Quarterly) | 72.62% |
| Profit Margin (Quarterly) | -78.26% |
| Earnings Yield | -66.49% |
| Operating Earnings Yield | 1.98% |
| Normalized Earnings Yield | -7.297 |